SCHEMBL3266830

SCHEMBL3266830

CCCCNCc1ccncc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.58
HRH3 Q9Y5N1 1/20 0.58
ALDH1A1 P00352 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
LMNA P02545 3/20 0.55
HTT P42858 1/20 0.55
CYP2D6 P10635 3/20 0.53
CYP2C19 P33261 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 2/20 0.51
NAMPT P43490 1/20 0.50
KDM4E B2RXH2 1/20 0.47
GLA P06280 1/20 0.47
CHRM2 P08172 2/20 0.46
MAOA P21397 1/20 0.45
S1PR2 O95136 1/20 0.45
S1PR4 O95977 1/20 0.45
S1PR1 P21453 1/20 0.45
S1PR3 Q99500 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2710961 0.98 HRH4 (0.56) HRH4HRH3ALDH1A1SMN1; SMN2LMNA
SCHEMBL2188159 0.94 HRH4 (0.67) HRH4HRH3ALDH1A1SMN1; SMN2LMNA
SCHEMBL19508848 0.92 HRH4 (0.65) HRH4HRH3ALDH1A1SMN1; SMN2LMNA
SCHEMBL3741348 0.88 ALDH1A1 (0.50) HRH4HRH3ALDH1A1SMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL5395461 0.86 ALDH1A1 (0.49) HRH4HRH3ALDH1A1SMN1; SMN2LMNA
SCHEMBL1659835 0.85 ALDH1A1 (0.71) HRH4HRH3ALDH1A1LMNACYP2D6
Acetic Acid SCHEMBL28476614 0.84 ALDH1A1 (0.68) HRH4HRH3ALDH1A1SMN1; SMN2LMNA
SCHEMBL29444840 0.83 MEN1 (0.56) ALDH1A1SMN1; SMN2CYP2D6CYP2C19CYP3A4
SCHEMBL21591483 0.82 ALDH1A1 (0.57) ALDH1A1CYP2D6CYP2C19CYP3A4KDM4E
SCHEMBL7992413 0.80 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2CYP2D6CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318782-B2 Mitotic kinesin inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-11-27 US disclosed
US-8236965-B2 Benzimidazole derivatives and their use as a medicament IPSEN PHARMA S.A.S. (FR) 2012-08-07 US disclosed
US-20120004262-A1 PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE ORYZON GENOMICS, S.A. (ES) 2012-01-05 US disclosed
US-20110275827-A1 Mitotic Kinesin Inhibitor FUJIFILM CORPORATION (JP) 2011-11-10 US disclosed
US-20110004000-A1 Mitotic Kinesin Inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-01-06 US disclosed
US-20090170922-A1 Benzimidazole derivatives and their use as a medicament SOCIETE DE CONSEILS DE RECHERECHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) 2009-07-02 US disclosed
US-7495110-B2 Benzimidazole derivatives and their use as GnRH antagonists SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004000-A1 Mitotic Kinesin Inhibitor KIF15, KIF5A, KIF5B HRH4 2703/4885HRH3 1769/4885ALDH1A1 2889/4885
US-20090170922-A1 Benzimidazole derivatives and their use as a medicament GNRHR, FSHR, KISS1R HRH4 102/4885HRH3 147/4885ALDH1A1 2294/4885
US-20120004262-A1 PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE PNMT, ABCB1, SNCA HRH4 833/4885HRH3 439/4885ALDH1A1 1344/4885
US-20110275827-A1 Mitotic Kinesin Inhibitor KIF15, KIF5A, KIF5B HRH4 2703/4885HRH3 1769/4885ALDH1A1 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.